MRC-Holland B.V.

MRC-Holland is a biotechnology company based in the Amsterdam Baarsjes. MRC-Holland consists of a multinational team. MRC-Holland is the inventor of the Multiplex Ligation-dependent Probe Amplification (MLPA) technique, a sensitive method to detect copy number changes in genes. MLPA is used by more than a thousand labs and hospitals worldwide for many different applications, including mutation detection in hereditary diseases and subtyping of tumours.

At MRC Holland, we believe that reliable genetic analysis should be available to everyone. Our mission is to provide the world with easy-to-use, high-quality and affordable genetic tools for diagnostic and research purposes.